BIOMAT Database Logo BIOMAT Database Logo

Synthesis and biological evaluation of novel indoline-2,3-dione derivatives as antitumor agents. 2014

Pengzhan Li, and Yanmei Tan, and Guyue Liu, and Yang Liu, and Jianzhen Liu, and Yanzhen Yin, and Guisen Zhao
Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University.

A new series of 1,5-disubstituted indolin-2,3-diones was synthesized and their inhibition of the growth of a human acute promyelocytic leukemia (HL-60) cell line was evaluated. These compounds had promising inhibition of HL-60 cell growth in vitro. Results indicated that compounds with a benzyl substituent at the N-1 position on the indolin-2,3-dione ring had more potent antiproliferative activity than those with a (4-fluorobenzyl) amino-2-oxoethyl substituent at the N-1 position. Among the compounds synthesized, compound 8l inhibited half of cell growth at a concentration of 0.07 μM and compound 8p did so at a concentration of 0.14 μM. These compounds may serve as lead compounds for further optimization in order to develop novel anticancer agents.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D018922 HL-60 Cells A promyelocytic cell line derived from a patient with ACUTE PROMYELOCYTIC LEUKEMIA. HL-60 cells lack specific markers for LYMPHOID CELLS but express surface receptors for FC FRAGMENTS and COMPLEMENT SYSTEM PROTEINS. They also exhibit phagocytic activity and responsiveness to chemotactic stimuli. (From Hay et al., American Type Culture Collection, 7th ed, pp127-8) HL60 Cells,Cell, HL60,Cells, HL60,HL 60 Cells,HL-60 Cell,HL60 Cell

Related Publications

Pengzhan Li, and Yanmei Tan, and Guyue Liu, and Yang Liu, and Jianzhen Liu, and Yanzhen Yin, and Guisen Zhao
Design, synthesis and preliminary biological evaluation of indoline-2,3-dione derivatives as novel HDAC inhibitors.
August 2015, Bioorganic & medicinal chemistry,
Pengzhan Li, and Yanmei Tan, and Guyue Liu, and Yang Liu, and Jianzhen Liu, and Yanzhen Yin, and Guisen Zhao
Novel indoline-2,3-dione derivatives as inhibitors of aminopeptidase N (APN).
May 2013, Bioorganic & medicinal chemistry,
Pengzhan Li, and Yanmei Tan, and Guyue Liu, and Yang Liu, and Jianzhen Liu, and Yanzhen Yin, and Guisen Zhao
Synthesis and biological evaluation of novel pazopanib derivatives as antitumor agents.
February 2014, Bioorganic & medicinal chemistry letters,
Pengzhan Li, and Yanmei Tan, and Guyue Liu, and Yang Liu, and Jianzhen Liu, and Yanzhen Yin, and Guisen Zhao
Synthesis and biological evaluation of novel acenaphthene derivatives as potential antitumor agents.
March 2011, Molecules (Basel, Switzerland),
Pengzhan Li, and Yanmei Tan, and Guyue Liu, and Yang Liu, and Jianzhen Liu, and Yanzhen Yin, and Guisen Zhao
Synthesis and biological evaluation of novel acylhydrazone derivatives as potential antitumor agents.
November 2013, Bioorganic & medicinal chemistry,
Pengzhan Li, and Yanmei Tan, and Guyue Liu, and Yang Liu, and Jianzhen Liu, and Yanzhen Yin, and Guisen Zhao
Synthesis of novel bis-anthraquinone derivatives and their biological evaluation as antitumor agents.
May 2013, Archives of pharmacal research,
Pengzhan Li, and Yanmei Tan, and Guyue Liu, and Yang Liu, and Jianzhen Liu, and Yanzhen Yin, and Guisen Zhao
Synthesis and biological evaluation of novel xanthine derivatives as potential apoptotic antitumor agents.
August 2019, European journal of medicinal chemistry,
Pengzhan Li, and Yanmei Tan, and Guyue Liu, and Yang Liu, and Jianzhen Liu, and Yanzhen Yin, and Guisen Zhao
Synthesis and biological evaluation of novel (thio)urea derivatives as potential antitumor agents.
November 2011, Archiv der Pharmazie,
Pengzhan Li, and Yanmei Tan, and Guyue Liu, and Yang Liu, and Jianzhen Liu, and Yanzhen Yin, and Guisen Zhao
Synthesis and biological evaluation of novel 2-arylvinyl-substituted naphtho[2,3-d]imidazolium halide derivatives as potent antitumor agents.
January 2018, European journal of medicinal chemistry,
Pengzhan Li, and Yanmei Tan, and Guyue Liu, and Yang Liu, and Jianzhen Liu, and Yanzhen Yin, and Guisen Zhao
Novel chiral matrine derivatives as potential antitumor agents: Design, synthesis and biological evaluation.
May 2024, Bioorganic chemistry,
Copied contents to your clipboard!